Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents
Cancers（2024）
Key words
Chronic Lymphocytic Leukemia (CLL),targeted therapies,Bruton Tyrosine Kinase inhibitors (BTKis),BCL-2 inhibitors (BCL-2is),adverse event management,Tumor Lysis Syndrome (TLS),cardiac toxicity,hematological toxicity,drug-drug interactions,infection management
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined